1-55051671-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_174936.4(PCSK9):c.524-607C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 203,198 control chromosomes in the GnomAD database, including 14,238 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.34 ( 10196 hom., cov: 32)
Exomes 𝑓: 0.37 ( 4042 hom. )
Consequence
PCSK9
NM_174936.4 intron
NM_174936.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.23
Publications
19 publications found
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
- hypercholesterolemia, autosomal dominant, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.345 AC: 52382AN: 151918Hom.: 10182 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
52382
AN:
151918
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.373 AC: 19064AN: 51160Hom.: 4042 Cov.: 0 AF XY: 0.379 AC XY: 10022AN XY: 26430 show subpopulations
GnomAD4 exome
AF:
AC:
19064
AN:
51160
Hom.:
Cov.:
0
AF XY:
AC XY:
10022
AN XY:
26430
show subpopulations
African (AFR)
AF:
AC:
129
AN:
626
American (AMR)
AF:
AC:
1847
AN:
3574
Ashkenazi Jewish (ASJ)
AF:
AC:
288
AN:
890
East Asian (EAS)
AF:
AC:
1585
AN:
2078
South Asian (SAS)
AF:
AC:
3073
AN:
7464
European-Finnish (FIN)
AF:
AC:
716
AN:
2260
Middle Eastern (MID)
AF:
AC:
46
AN:
150
European-Non Finnish (NFE)
AF:
AC:
10440
AN:
31532
Other (OTH)
AF:
AC:
940
AN:
2586
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
540
1080
1620
2160
2700
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.345 AC: 52427AN: 152038Hom.: 10196 Cov.: 32 AF XY: 0.348 AC XY: 25862AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
52427
AN:
152038
Hom.:
Cov.:
32
AF XY:
AC XY:
25862
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
9063
AN:
41494
American (AMR)
AF:
AC:
7581
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1197
AN:
3472
East Asian (EAS)
AF:
AC:
3940
AN:
5158
South Asian (SAS)
AF:
AC:
2137
AN:
4808
European-Finnish (FIN)
AF:
AC:
3281
AN:
10564
Middle Eastern (MID)
AF:
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24028
AN:
67952
Other (OTH)
AF:
AC:
813
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1678
3355
5033
6710
8388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2025
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.